CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Grnenthal's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 13, 2022Prolonged Release Dosage Form Of Tapentadol L-(+)- Tartaric Acid Salt2
Nov 17, 2021Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol3
Apr 14, 2021Salts Or Co-Crystals Of 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol6
Jul 22, 2020(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful Inflammations4
Apr 22, 2020Aqueous Pharmaceutical Formulation Of Tapentadol For Oral Administration1
Oct 2, 2019Tapentadol For Treating Pain Associated With Trigeminal Neuralgia1
Oct 31, 2018Tapentadol For Preventing Chronification Of Pain3
Mar 22, 2017Break-Resistant Delayed-Release Forms Of Administration1